Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Entergy
ETR
$48.8B
| $153M | 0.24% |
3,559,004
-3,485,960
| -49% | -$148M |
|
77
SBA Communications
SBAC
$19.4B
| $151M | 0.24% |
931,721
+664,371
| +249% | +$108M |
|
78
Boeing
BA
$169B
| $147M | 0.23% |
454,421
+42,651
| +10% | +$14.7M |
|
|
SEE
79
DELISTED
Sealed Air
SEE
| $145M | 0.23% |
4,170,483
+3,821,054
| +1,094% | +$133M |
|
80
Humana
HUM
$45.5B
| $144M | 0.22% |
503,066
+331,263
| +193% | +$105M |
|
81
Akamai
AKAM
$15.9B
| $144M | 0.22% |
2,351,173
+1,616,320
| +220% | +$108M |
|
82
Williams Companies
WMB
$86.2B
| $143M | 0.22% |
6,501,586
+2,599,181
| +67% | +$65M |
|
83
Morgan Stanley
MS
$336B
| $140M | 0.22% |
3,533,167
-457,057
| -11% | -$19.9M |
|
84
NiSource
NI
$19.5B
| $140M | 0.22% |
5,509,983
+416,570
| +8% | +$10.7M |
|
85
CALL
SPDR Gold Trust
GLD
$152B
| $139M | 0.22% |
1,150,000
-100,000
| -8% | -$11.6M |
|
86
Union Pacific
UNP
$183B
| $139M | 0.22% |
1,008,510
-351,527
| -26% | -$52.1M |
|
87
Northrop Grumman
NOC
$78.3B
| $139M | 0.22% |
568,441
+378,176
| +199% | +$104M |
|
88
Kinder Morgan
KMI
$69B
| $139M | 0.22% |
9,022,925
+8,312,075
| +1,169% | +$141M |
|
89
Philip Morris
PM
$293B
| $139M | 0.22% |
2,076,386
+1,620,613
| +356% | +$135M |
|
90
Procter & Gamble
PG
$336B
| $137M | 0.21% |
1,493,092
+1,459,117
| +4,295% | +$130M |
|
91
Evergy
EVRG
$18.7B
| $136M | 0.21% |
2,392,931
-2,819,727
| -54% | -$163M |
|
92
NRG Energy
NRG
$23.8B
| $135M | 0.21% |
3,409,526
-268,402
| -7% | -$10.3M |
|
|
ATHN
93
DELISTED
Athenahealth, Inc.
ATHN
| $135M | 0.21% |
+1,022,505
| New | +$131M |
|
94
SM Energy
SM
$8.85B
| $133M | 0.21% |
8,613,431
+2,348,170
| +37% | +$54.3M |
|
95
PUT
Meta Platforms (Facebook)
META
$1.4T
| $133M | 0.21% |
1,015,100
+95,200
| +10% | +$13.8M |
|
96
Regions Financial
RF
$25.9B
| $133M | 0.21% |
9,917,623
-6,186,110
| -38% | -$99.4M |
|
|
VAR
97
DELISTED
Varian Medical Systems, Inc.
VAR
| $132M | 0.21% |
1,165,555
+824,675
| +242% | +$94.3M |
|
98
Intuitive Surgical
ISRG
$134B
| $132M | 0.21% |
824,061
-922,845
| -53% | -$156M |
|
|
99
CALL
Amazon
AMZN
$2.79T
| $131M | 0.2% |
1,742,000
+1,722,000
| +8,610% | +$143M |
|
100
CALL
Invesco QQQ Trust
QQQ
$486B
| $130M | 0.2% |
840,100
+814,900
| +3,234% | +$136M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.